Careers Contact

Evaxion > Investors

Investors

Since 2021, Evaxion has been listed on the Nasdaq Capital Market exchange (ticker code: EVAX). Here you can find all of the latest Evaxion investor insights: our results, upcoming events and news, important shareholder updates and much more.

Latest press releases

Evaxion to present new data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia, at the EHA 2026 Congress

Evaxion announces business update and first quarter 2026 financial results

Evaxion to announce business update and first quarter 2026 financial results on May 7, 2026

Upcoming events & presentations

May 26 – May 29, 2026

Thessaloniki, Greece

RECOMB 2026

RECOMB 2026 is the 30th edition of a series of algorithmic computational biology conferences bridging the areas of computational, mathematical, statistical and biological sciences. The conference features keynote talks by preeminent scientists in life sciences, presentations of ground breaking research in computational biology, selected over the course of a highly-rigorous peer-review process, and poster sessions on the latest research progress.

Latest events & presentations

May 20 – May 21, 2026

AGP Annual Virtual Healtcare Conference

The A.G.P. (Alliance Global Partners) Annual Virtual Healthcare Conference is a recurring event that features presentations and fireside chats from various life science, biopharmaceutical, and medical technology companies.

Q1

Latest quarterly report

View all financial reports

Presentation

Webcast

Transcript

Press release

SEC filing

Contact IR

Mads Kronborg
Vice President, Investor Relations & Communication
Email: mak@evaxion.ai
Telephone: +45 53 54 82 96

Company presentation

Stay in touch

LinkedIn

Follow Evaxion on LinkedIn to engage, connect, and stay informed.

Twitter

Join the conversation and stay updated with Evaxion on X.

Subscribe to email news alerts

Join our mailing list to get our latest press releases delivered straight to your inbox.